INTERLIFESCIENCE is a Swiss registered company located in the Canton Ticino, in the southwest part of Switzerland. It operates internationally.
INTERLIFESCIENCE performs promotion and consulting in all fields of microbiology, but particularly those related to human beings.
The Round Table Antibiotics is a Swiss non-profit interdisciplinary Association gathering experts from medicine, research and economics of almost all Swiss universities, as well as committed personalities from industry or elsewhere.
The aim of the Association Round Table Antibiotics is to drive Switzerland’s contribution to innovation, research, and development of measures against antimicrobial resistance, particularly by promoting the market introduction of new active substances, which should be available to all countries worldwide.
Additional information: www.roundtableantibiotics.ch
On 9 November 2017, the Round Table on Antibiotics launched an appeal to the Federal Council to establish a dialogue in Switzerland between all partners involved in antibiotic research (academic research, economics, small and medium-sized enterprises, pharmaceutical industry, etc.). This dialogue should aim at defining, developing and implementing an innovative financing model for the research, development and marketing of new antibiotics that are financially accessible to all.
The text of the call of November 9, 2017 can be seen under "Publications"
With the purpose of raising awareness of antibiotic resistance and improving the prudent use of antimicrobials, WHO (World Health Organisation) is organising a World Antibiotic Awareness Week since 2015. This year the event will be held from November 13 to 19. For the first time, Switzerland will actively participate to this week. Indeed, the crisis of bacterial resistance to antibiotics is such that an increasing number of infections is becoming difficult to treat, or even impossible. WHO is deeply concerned with this issue and is stimulating its state members to organise campaigns at the national level. Switzerland has already reacted to the antibiotic resistance issue by promoting a National Research Programme of 20 millions CHF(NRP 72) as well as a national Strategy on antibiotic resistance (StAR).